ENFERMEDADES INFECCIOSAS
Instituto de Investigación Sanitaria Biobizkaia
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (16)
2024
-
Description of reinfection of joint prosthesis after 2-stage replacement (infection of the 2nd stage prosthesis): A multicenter study
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 7, pp. 354-360
-
Impact of antibiotic prophylaxis in second-stage surgery in joint prosthesis infection treated with two-stage exchange. A multicenter case–control study
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 7, pp. 1319-1328
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial
Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
2022
-
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966
-
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial
JAMA Network Open, Vol. 5, Núm. 1
-
Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic
Journal of Psychiatric Research, Vol. 149, pp. 10-17
2021
-
Author Correction: Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America (Scientific Reports, (2021), 11, 1, (11442), 10.1038/s41598-021-90023-x)
Scientific Reports
-
Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America
Scientific Reports, Vol. 11, Núm. 1
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
-
Molecular characterization of multidrug resistant Enterobacterales strains isolated from liver and kidney transplant recipients in Spain
Scientific Reports, Vol. 11, Núm. 1
-
Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia: Study protocol for the SAFO trial
BMJ Open, Vol. 11, Núm. 8
-
T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19
Frontiers in Immunology, Vol. 12
2020
2015
-
Effectiveness and safety of medium-dose prednisone in giant cell arteritis: a retrospective cohort study of 103 patients
Clinical and experimental rheumatology, Vol. 33, Núm. 2